2 active not recruiting, 1 enrolling by invitation, 1 terminated. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Active not recruiting 2, Enrolling by invitation 1, Terminated 1 |
Follow INFANRIX: new trials by email Literature Review of INFANRIX trials Research Report on INFANRIX
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ESCUDDO Long Term Follow Up Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed, Recombinant Human Papillomavirus Nonavalent Vaccine - Human Papillomavirus Infection, Human Papillomavirus-Related Malignant Neoplasm | Phase 4 | Enrolling by invitation | National Cancer Institute (NCI) | 13700 | 2026-08-11 | 2026-09-22 |
| Single-Dose HPV Vaccination for the Prevention of Cervical Cancer in Young Adult Women in Costa Rica, The PRISMA ESCUDDO Trial Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed, Questionnaire Administration, Recombinant Human Papillomavirus Bivalent Vaccine - Human Papillomavirus-Related Cervical Carcinoma | Phase 4 | Active not recruiting | National Cancer Institute (NCI) | 5000 | 2022-03-01 | 2026-10-22 |
| Comparing One or Two Doses of the Human Papillomavirus Vaccine for the Prevention of Human Papillomavirus Infection, ESCUDDO Study Diphtheria Toxoid/Tetanus Toxoid/Acellular Pertussis Vaccine Adsorbed, Questionnaire Administration, Recombinant Human Papillomavirus Bivalent Vaccine - Human Papillomavirus Infection, Human Papillomavirus-Related Cervical Carcinoma | Phase 4 | Active not recruiting | National Cancer Institute (NCI) | 27945 | 2017-11-29 | 2025-09-04 |
| Immunogenicity, Antibody Persistence and Safety of GSK Biologicals' DTPa (INFANRIX) and dTpa (BOOSTRIX) Vaccines. INFANRIX, BOOSTRIX, HAVRIX - Acellular Pertussis, Tetanus | Phase 4 | Terminated | GlaxoSmithKline | 720 | 2003-05-01 | 2016-09-07 |
Papillomavirus Infections (2) · Diphtheria (1) · Tetanus (1)
National Cancer Institute (NCI) (3) · GlaxoSmithKline (1)
Costa Rica (3) · Australia (1)
Aimee R Kreimer (2) · Aimee Kreimer (1)
PMID 41276263, PMID 32078808, PMID 33857679, PMID 34857420, PMID 41337735